WATSON 152 8 mg Pill - white capsule/oblong, 19mm

Generic Name: silodosin

Pill with imprint WATSON 152 8 mg is White, Capsule/Oblong and has been identified as Rapaflo 8 mg. It is supplied by Allergan, Inc.

Rapaflo is used in the treatment of Benign Prostatic Hyperplasia and belongs to the drug class alpha blockers. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 152 8 mg

Rapaflo

Generic Name

silodosin

Imprint

WATSON 152 8 mg

Strength

8 mg

Color

White

Size

19.00 mm

Shape

Capsule/Oblong

Availability

Prescription only

Drug Class

Alpha blockers

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Allergan, Inc.

National Drug Code (NDC)

52544-0152 (Discontinued)

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer